Axxam GmbH is the German subsidiary of Axxam S.p.A. created on January 1, 2022 from the merger of Hit Discovery Constance GmbH and IMAX Discovery GmbH. Axxam GmbH is structured into two business units, namely Discovery Services Constance (“DSC”) and IMAX Discovery, deriving respectively from the two original companies.
Under the new name we will continue to offer our competences, resources and experience to our customers and partners in order to support their research projects and face together the new challenges with a joint and integrated approach.
About the Business Unit Discovery Services Constance deriving from Hit Discovery Constance GmbH
In 2014 Hit Discovery Constance GmbH (“HDC”) was founded as a joint venture company between Axxam S.p.A. (Milan, Italy), Centre for Drug Design and Discovery of KU Leuven (Leuven, Belgium) and Lead Discovery Center GmbH (Dortmund, Germany). In 2021 Axxam S.p.A. announced the entire acquisition of the share capital of Hit Discovery Constance GmbH which in the meanwhile became a qualified provider of early-stage drug discovery services for the life sciences industry, staffed and operated by experienced scientists who have run drug discovery and HTS projects in major pharmaceutical, biotechnology and academic institutions in Germany and around the world.
The high-quality services include high-throughput screening (1536 and 384 well formats) and radiometric screening (SPA, flash-plate).
About the Business Unit IMAX Discovery deriving from IMAX Discovery GmbH
IMAX Discovery GmbH is a research company incorporated in 2011 as an equity joint venture between IMD Natural Solutions GmbH (INS), a specialist in the field of natural products, and Axxam S.p.A., a leading company in discovery research.
Since its foundation IMAX Discovery has been involved in numerous successful R&D projects performed together with renowned companies in the food & beverage industry as well as flavor houses. Thanks to the long collaboration history, IMAX Discovery has gained an excellent reputation as innovator for new taste modulating ingredients and is trusted by various leading companies in the field.
In early 2018 IMAX Discovery became a 100% subsidiary of Axxam S.p.A., with the consequent acquisition of the natural product libraries of INS. Concurrently, Axxam transferred its service business within the fragrance field into IMAX Discovery.
IMAX Discovery offers its clients and partners integrated solutions across the entire discovery process starting from flavor, fragrance and cosmetic target identification and validation up to the selection and development of new bioactive compounds by providing services, tools and integrated solutions tailored to the specific needs of its clients and partners.